Plasma Brain-Derived Neurotrophic Factor as a Biomarker for the Main Types of Mild Neurocognitive Disorders and Treatment Efficacy: A Preliminary Study

Table 2

Plasma BDNF levels (mean ± SD) in comparison groups at baseline, pg/mL.

Comparison groups			value
WCI ( = 16)	MNCD-AD; ( = 21)	ScVMNCD; ( = 22)	WCI versus MNCD-AD	WCI versus ScVMNCD	MNCD-AD versus ScVMNCD
31581.5 ± 8092.2	19950.7 ± 9678.8	25939.6 ± 10410.5	0.0025	0.21	0.13

: number of patients.
according to post hoc Scheffe test.